Modlin, I M <br/><br/>
Molecular strategies and 111in-labelled somatostatin analogues in defining the management of neuroendocrine tumour disease: a new paradigm for surgical management.  [electronic resource] 

 -  The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland  Jun 2003 
 - 137-43 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1479-666X 
<br/><br/><label>Standard No.: </label>10.1016/s1479-666x(03)80092-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Cycle<br/>Cell Proliferation<br/>Databases, Genetic<br/>Disease Models, Animal<br/>Drug Delivery Systems<br/>Enterochromaffin Cells--physiology<br/>Gene Expression Profiling<br/>Humans<br/>Indium Radioisotopes<br/>Muridae<br/>Neuroendocrine Tumors--diagnostic imaging<br/>Oligonucleotide Array Sequence Analysis<br/>Radionuclide Imaging<br/>Receptors, Somatostatin--genetics<br/>Somatostatin--analysis